Hyperpigmentation Disorders Treatment Market by Treatment Type (Topical Drugs, Chemical Peels, Phototherapy, Laser Therapy, and Microdermabrasion), Disease Indication (Melasma, Solar Lentigines, and Post-inflammatory Hyperpigmentation), End User (Dermatology Centers, Aesthetic Clinics, and Hospitals) - Global Analysis & Forecast 2019-2030

Market Industry Reports (MIR) has published a new report titled “Hyperpigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global hyperpigmentation disorders treatment market is estimated to be over US$ 3.5 Bn in 2017. It is anticipated to grow at a substantial CAGR from 2019 to 2030.

Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hyperpigmentation disorders treatment market. Moreover, rising adoption of minimally invasive procedure, increasing medical tourism for aesthetics is anticipated to be the major drive the growth of the global hyperpigmentation disorders treatment market between 2019 and 2030.

Increasing Geriatric Population

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global hyperpigmentation disorders treatment market in the coming times. Since, growing age brings about several changes in the skin conditions, namely melisma, solar lentigines and other forms of hyperpigmentation.

Increasing Adoption of Minimally-Invasive Procedures

Since the advent of minimally-invasive procedures, the adoption of such procedures have witnessed substantial growth in recent times. Shorter hospital admittance time, lesser procedure associated pain and fewer complications have been pivotal in contributing to the growing adoption of minimally-invasive procedures. According to the American Society of Plastic Surgeons (ASPS), the numbers of Americans opting for minimally-invasive cosmetic procedures have witnessed a growth of nearly 200% since 2000.  In 2017, the total number of cosmetic procedures performed in U.S. was nearly 1.8 million. Growing preference for minimally-invasive cosmetic procedures in anticipated to further propel the growth of the hyperpigmentation disorders treatment market.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Hyperpigmentation Disorders Treatment Market by Treatment Type (Topical Drugs, Chemical Peels, Phototherapy, Laser Therapy, and Microdermabrasion), Disease Indication (Melasma, Solar Lentigines, and Post-inflammatory Hyperpigmentation), End User (Dermatology Centers, Aesthetic Clinics, and Hospitals) - Global Analysis & Forecast 2019-2030   in detail along with the table of contents: https://www.marketindustryreports.com/36/hyperpigmentation-disorders-treatment-market

Complications and Risk Related Associated with Cosmetic Treatments to Restrain the Market

Various complications and risk related to cosmetic treatments have been major factors that have been affecting the growth of the hyperpigmentation disorders treatment industry inversely. Several complications such as nerve damage, infections, seroma and pulmonary embolism are known to cause serious adverse and side effects as a result of different cosmetic or aesthetic treatments. Similarly, patients have reported granulomas, and infections as long-term adverse effects caused as a result of cosmetic treatments.

 Rapid Growth of the Asia Pacific Market

Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing population, continuously growing economy, rising medical tourism and increasing awareness regarding cosmetic treatment and increasing adoption of latest technologies is anticipated to present a lucrative growth scenario for the hyperpigmentation disorders treatment market in this region. Furthermore, attractive rates of treatment, coupled with supportive government healthcare regulations and norms is expected to present an attractive growth prospect for the market in the coming years.

 Major Players in the Hyperpigmentation Disorders Treatment Market

The prominent players in the global Hyperpigmentation Disorders Treatment market are Bayer AG, RXi Pharmaceuticals, ALLERGAN, Galderma laboratories, SkinCeuticals International, PIERRE FABRE GROUP, EpiPharm AG, Obagi Cosmeceuticals LLC., and VIVIERPHARMA among others

About Us

Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.

We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us

sales@marketindustryreports.com